CD274 and neoplasm: Although its mechanism in the immune tolerance has been known and applied in cancer research and clinical treatment, PD-L1 expressed themselves in membrane and cytoplasm of cancer cells intrinsically [13], in which it takes a role of “shield” to prevent tumor cells from catalyzing [14].